Maura L. Gillison

Rush University Medical Center — United States

Medicine · Health Sciences

97h-index58.8kcitations600works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(298), Cervical Cancer and HPV Research(141), Cancer Immunotherapy and Biomarkers(107), Cancer Genomics and Diagnostics(64), Lung Cancer Treatments and Mutations(61)

Publications600 total

Supplementary Figures S1-S6 and Tables S1-S5 from Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration
2025Open Access
Supplementary Video: HPV and Heterocateny from Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration
2025Open Access
Treatment Interruption and Outcomes in Head and Neck Cancer
JAMA Otolaryngology–Head & Neck Surgery·2025Open Access
Supplementary Table S3 from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
2025Open Access
Supplementary Table S1 from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
2025Open Access
Supplementary Table S2 from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
2025Open Access
Trastuzumab Deruxtecan in HER2-Low or HER2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case Series
Journal of the National Comprehensive Cancer Network·2025
Abstract B084: Clinical Outcomes and Biomarker Correlates of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Novel Immunotherapies in Phase 1 Trials
Molecular Cancer Therapeutics·2025
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
UNC Libraries·2025Open Access
Supplementary Fig. S7. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Table S2. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Table S20. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Fig. S11. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Table S16. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Table S15. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Table S21. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Fig. S16. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Fig. S12. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Table S1. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
Supplementary Fig. S17. from Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers
2025Open Access
page 1 of 30Next →

Frequent Co-authors

A. Dimitrios Colevas(12), Richard C. Jordan(11), Randal S. Weber(10), Robert I. Haddad(10), Anil K. Chaturvedi(10), Weihong Xiao(9), William H. Westra(8), Anthony J. Cmelak(8), Loren K. Mell(8), John A. Ridge(8), Sue S. Yom(8), Barbara Burtness(8), Christine H. Chung(7), David G. Pfister(7), David M. Brizel(7), Jimmy J. Caudell(7), David W. Eisele(7), Wesley L. Hicks(7), Ying J. Hitchcock(7), Ellie Maghami(7)